痰热清注射液治疗全身炎症反应综合征的临床效果探究

目的：本研究旨在对痰热清注射液治疗全身炎症反应综合征的临床效果展开研究和探讨。方法：取我科自2011年6月以来收治的全身炎症反应综合征患者68例，随机分为实验组和对照组，其中34例患者采用常规抗感染治疗，视为对照组；另外34例患者在对照组的基础上静脉注射痰热清注射液，视为实验组。对两组患者治疗前后心率（HR）、呼吸频率、（RR）、体温（T）、中性粒细胞百分比和白细胞计数（WBC）变化情况进行统计后对比分析；同时观察两纽患者脓毒症和死亡的发生情况。结果实验组治疗前后心率、呼吸频率和白细胞计数的改善明显优于对照组；实验组脓毒症和死亡率更低；且上述比较项差异均具统计学意义（P〈0．05）。结论：痰热清注射液治疗全身炎症反应综合征的，临床治疗效果明显，能显著改善并稳定患者炎症反应，值得在临床上进一步推广。

Discussion on the clinical effect of Tanreqing injection on treating SIRS

Objective： This study aims to Tanreqing injection treatment of systemic inflammatory response syndrome （SIRS） effects a study and discussion. Methods： 68 cases of SIRS patients in our department since June 2011 were randomly divided into experimental group and control group, 34 patients were treated with conventional anti-infection treatment, as the control group; another 34 patients were given intravenous Tanreqing based on the control group, as the experimental group. Two groups of patients before and after treatment for heart rate （HR）, respiratory rate, （RR）, temperature （T）, the percentage ofneutrophils and white blood cell count （WBC） after changes were statistically analyzed; also observed sepsis and death situation of patients. Results： The heart rate, respiratory rate, and white blood cell count of experimental group before and after treatment improved more significantly than the control group; sepsis and mortality rate of experimental group were lower; and the above comparable items had statistically significant differences （P〈0.05）. Conclusion： Tanreqing injection has obvious effect on SIRS, can significantly improve and stabilize the patient inflammation, is worthy of clinical further promotion.